← Back to Analyst Consensus 
CGEN Buy
COMPUGEN LTD
Current Price —
Implied Upside —
Analysts 11
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 1 reiterations from 1 firms
Next Earnings
Nov 16, 2026 (21 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 12, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| May 21, 2026 | Leerink Partners | maintain | Outperform → Outperform | — | 51% |
| Apr 7, 2026 | Lake Street | initiate | — → Buy | — | 47% |
| Jan 7, 2026 | HC Wainwright & Co. | initiate | — → Buy | $4 | 44% |
| May 21, 2024 | Truist Securities | maintain | Buy → Buy | $4 | 54% |
| Mar 8, 2024 | Truist Securities | maintain | Buy → Buy | $5 | 54% |
| Dec 19, 2023 | Stifel | maintain | Buy → Buy | $4 | 53% |
| Aug 23, 2023 | Truist Securities | reiterate | Buy → Buy | $4 | 54% |
| Aug 7, 2023 | EF Hutton | reiterate | Buy → Buy | $13 | 30% |
| Jun 6, 2023 | EF Hutton | reiterate | — → Buy | $13 | 30% |
| May 26, 2023 | EF Hutton | reiterate | Buy → Buy | $13 | 30% |
| May 24, 2023 | EF Hutton | reiterate | Buy → Buy | $13 | 30% |
| May 16, 2023 | Oppenheimer | maintain | Outperform → Outperform | $7 | 52% |
| Feb 28, 2023 | Oppenheimer | reiterate | — → Outperform | $8 | 52% |
| Feb 8, 2023 | Jefferies | downgrade | Hold → Underperform | $0.5 | 52% |
| Jan 5, 2023 | EF Hutton | initiate | — → Buy | $13 | 30% |
| Nov 15, 2022 | Oppenheimer | maintain | — → Outperform | $8 | 52% |
| Aug 23, 2022 | Truist Securities | maintain | — → Buy | $4 | 54% |
| Aug 8, 2022 | JMP Securities | maintain | — → Market Outperform | $4 | 53% |
| Aug 8, 2022 | Oppenheimer | maintain | — → Outperform | $12 | 52% |
| Aug 5, 2022 | Jefferies | downgrade | Buy → Hold | $2 | 52% |
| Feb 25, 2022 | Oppenheimer | maintain | — → Outperform | $14 | 52% |
| Feb 25, 2022 | SVB Leerink | maintain | — → Outperform | $9 | — |
| Apr 6, 2021 | SVB Leerink | maintain | — → Outperform | $16 | — |
| Aug 19, 2020 | SVB Leerink | maintain | — → Outperform | $19 | — |
| May 13, 2020 | Stifel | initiate | — → Buy | $19 | 53% |
| May 7, 2020 | SVB Leerink | initiate | — → Outperform | $15 | — |
| Apr 22, 2020 | Roth Capital | initiate | — → Buy | $28 | 53% |
| Mar 24, 2020 | SunTrust Robinson Humphrey | initiate | — → Buy | $16 | — |
| Feb 21, 2020 | Cantor Fitzgerald | reiterate | — → Overweight | $13 | 50% |
| Jan 16, 2020 | Cantor Fitzgerald | initiate | — → Overweight | $10 | 50% |
| Mar 29, 2018 | Oppenheimer | initiate | — → Outperform | $9 | 52% |
| Mar 9, 2016 | JMP Securities | maintain | — → Market Outperform | $11 | 53% |
| Oct 15, 2015 | FBR Capital | initiate | — → Outperform | $14 | — |
| Oct 15, 2015 | Cowen & Co. | initiate | — → Outperform | $14 | — |
| Apr 21, 2015 | Oppenheimer | initiate | — → Outperform | $11 | 52% |
| Jun 18, 2014 | JMP Securities | initiate | — → Market Outperform | $14 | 53% |
| Mar 19, 2014 | Jefferies | initiate | — → Buy | $17 | 52% |
| Feb 6, 2014 | McNicoll Lewis Vlak | initiate | — → Buy | $14 | — |
Price Target Trend
Jun 9, 2026 Oct 26, 2026
EPS Estimates
+1q —
0q —
0y —
+1y —
Cross-Platform Signals
No cross-platform signals in the last 90 days